LOPOLIN

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Nov 2025 filing date already counts against anyone who files later.

Record

Serial number

99490068

Mark type

Stylized text

Filed

11 Nov 2025

Published for opposition

14 Apr 2026

Attorney of record

RAN HE

Goods and services

• Class 005 — Pharmaceuticals: Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Anti-inflammatory preparations; Dermatological pharmaceutical products; Dietary supplements; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Nutritional supplements; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical antitussive-cold preparations; Preparation for the relief of pain; Probiotic supplements; Vitamin supplements; Anti-inflammatories; Anxiolytics

Owner

• Lopolin Research Institute Inc., Edmonton, AB, CA

Prosecution history

• 20 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 20 Mar 2026 — ASSIGNED TO EXAMINER
• 11 Nov 2025 — APPLICATION FILING RECEIPT MAILED
• 11 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 11 Nov 2025 — NEW APPLICATION ENTERED